E R Dorsey

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. doi Funding of Parkinson research from industry and US federal and foundation sources
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 24:731-7. 2009
  2. pmc Financing of U.S. biomedical research and new drug approvals across therapeutic areas
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, United States of America
    PLoS ONE 4:e7015. 2009
  3. pmc Selegiline shortage: Causes and costs of a generic drug shortage
    E R Dorsey
    Department of Neurology, University at Buffalo, NY, USA
    Neurology 73:213-7. 2009
  4. doi Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:1652-9. 2010
  5. pmc The economics of new faculty hires in basic science
    E Ray Dorsey
    University of Rochester School of Medicine and Dentistry, University of Rochester, Rochester, New York 14620, USA
    Acad Med 84:26-31. 2009
  6. doi Communicating clinical trial results to research participants
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, 1351 Mt Hope Ave, Ste 223, Rochester, NY 14620, USA
    Arch Neurol 65:1590-5. 2008
  7. pmc Funding of US biomedical research, 2003-2008
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    JAMA 303:137-43. 2010
  8. ncbi Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
    E R Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Neurology 68:1524-8. 2007
  9. ncbi Financial anatomy of neuroscience research
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA
    Ann Neurol 60:652-9. 2006
  10. doi A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:2128-35. 2010

Detail Information

Publications27

  1. doi Funding of Parkinson research from industry and US federal and foundation sources
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 24:731-7. 2009
    ..These companies will likely require partnerships to drive successful development of new PD therapies...
  2. pmc Financing of U.S. biomedical research and new drug approvals across therapeutic areas
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, United States of America
    PLoS ONE 4:e7015. 2009
    ..We estimated U.S. biomedical research funding across therapeutic areas, determined the association with disease burden, and evaluated new drug approvals that resulted from this investment...
  3. pmc Selegiline shortage: Causes and costs of a generic drug shortage
    E R Dorsey
    Department of Neurology, University at Buffalo, NY, USA
    Neurology 73:213-7. 2009
    ..We sought to evaluate prescription trends of generic selegiline and to quantify the economic impact of any resulting drug substitution of more expensive alternatives...
  4. doi Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:1652-9. 2010
    ..Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible...
  5. pmc The economics of new faculty hires in basic science
    E Ray Dorsey
    University of Rochester School of Medicine and Dentistry, University of Rochester, Rochester, New York 14620, USA
    Acad Med 84:26-31. 2009
    ..To compare the streams of expenses and revenues associated with investment in a cohort of basic science investigators at the University of Rochester School of Medicine & Dentistry for seven years...
  6. doi Communicating clinical trial results to research participants
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, 1351 Mt Hope Ave, Ste 223, Rochester, NY 14620, USA
    Arch Neurol 65:1590-5. 2008
    ..Communicating clinical trial results to research participants is seldom accomplished in a timely or an effective manner...
  7. pmc Funding of US biomedical research, 2003-2008
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    JAMA 303:137-43. 2010
    ..With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown...
  8. ncbi Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
    E R Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Neurology 68:1524-8. 2007
    ..033 QALYs (12 quality-adjusted days) gained. For context, we performed an analogous calculation for interferon beta-1a, which also had a net health benefit of 0.033 QALYs (12 quality-adjusted days)...
  9. ncbi Financial anatomy of neuroscience research
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA
    Ann Neurol 60:652-9. 2006
    ..To estimate the level of funding for neuroscience research from federal and industry sources and to examine the therapeutic advances in the neurosciences over the past decade...
  10. doi A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:2128-35. 2010
    ..Specialty care and improved education, in the clinic or through support groups, may enhance satisfaction and health care quality...
  11. ncbi An evaluation of four proposals to reduce the financial burden of medical education
    E Ray Dorsey
    University of Rochester Medical Center, 1351 Mt Hope Ave, Suite 223, Rochester, NY 14620, USA
    Acad Med 81:245-51. 2006
    ....
  12. ncbi Biomarkers in Parkinson's disease
    E Ray Dorsey
    University of Rochester Medical Center, 1351 Mt Hope Avenue, Suite 223, Rochester, NY 14620, USA
    Expert Rev Neurother 6:823-31. 2006
    ..However, to date, biomarkers, despite their considerable promise, have had limited utility in clinical trials and practice...
  13. ncbi Predictors of future publication record and academic rank in a cohort of neurology residents
    E Ray Dorsey
    Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Neurology 67:1335-7. 2006
    ..01) and during (p < 0.001) residency was associated with higher post-residency publication rates. Publication differences between women and men (1.5 vs 2.4 publications/year; p = 0.03) warrant further investigation...
  14. ncbi Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
    E R Dorsey
    Department of Neurology, University of Rochester Medical Center, 1351 Mt Hope Blvd, Suite 223, Rochester, NY 14620, USA
    Neurology 68:384-6. 2007
    ..The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030...
  15. pmc Quantitative risk-benefit analysis of natalizumab
    J P Thompson
    Department of Neurology, University of Rochester, Rochester, NY, USA
    Neurology 71:357-64. 2008
    ..To model the long-term risks and benefits of natalizumab in individuals with relapsing multiple sclerosis (MS)...
  16. pmc Group patient visits for Parkinson disease: a randomized feasibility trial
    E R Dorsey
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Neurology 76:1542-7. 2011
    ..This care delivery method has demonstrated benefits for individuals with chronic conditions but has not been evaluated for Parkinson disease (PD)...
  17. doi Telemedicine for the care of nursing home residents with Parkinson's disease
    Kevin M Biglan
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 24:1073-6. 2009
    ..The visits resulted in improvements in motor and cognitive symptoms and suggest that telemedicine may be useful for delivering care to this population...
  18. pmc Local institutional review board (IRB) review of a multicenter trial: local costs without local context
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Ann Neurol 67:258-60. 2010
    ..This may be an opportune time for the National Institute of Neurological Disorders and Stroke (NINDS) to adopt a central review model...
  19. pmc Altered cholesterol and fatty acid metabolism in Huntington disease
    Robert C Block
    Division of Epidemiology, Department of Community and Preventive Medicine and Preventive Cardiology Unit, Box 644, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14620, USA
    J Clin Lipidol 4:17-23. 2010
    ..Drugs that combat the dysregulated lipid milieu in Huntington disease may help treat this perplexing and catastrophic genetic disease...
  20. doi Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington disease
    E R Dorsey
    Department of Neurology, Johns Hopkins Medicine, Baltimore, MD, USA
    Clin Genet 84:251-7. 2013
    ..Thus, among individuals affected by HD, familiarity with and knowledge of GINA are low. The effectiveness of the legislation may be limited by this lack of knowledge. ..
  21. pmc Pivotal studies of orphan drugs approved for neurological diseases
    Jun Mitsumoto
    College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Ann Neurol 66:184-90. 2009
    ..To identify design elements of clinical trials leading to US Food and Drug Administration approval of drugs for neurological diseases with and without orphan indications...
  22. ncbi The influence of controllable lifestyle and sex on the specialty choices of graduating U.S. medical students, 1996-2003
    E Ray Dorsey
    University of Rochester, School of Medicine and Dentistry, 1351 Mt Hope Avenue, Suite 223, Rochester, NY 14620, USA
    Acad Med 80:791-6. 2005
    ..To determine whether the preferences of female medical students are sufficient to explain the recent trend of U.S. medical students choosing specialties with controllable lifestyles...
  23. doi Impact of FDA black box advisory on antipsychotic medication use
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, New York, USA
    Arch Intern Med 170:96-103. 2010
    ..The impact of these warnings on atypical drug use is unknown...
  24. doi A randomized, placebo-controlled trial of latrepirdine in Huntington disease
    Karl Kieburtz
    Department of Neurology, University of Virginia, Charlottesville, VA 22908, USA
    Arch Neurol 67:154-60. 2010
    ..To evaluate the safety and tolerability of latrepirdine in Huntington disease (HD) and explore its effects on cognition, behavior, and motor symptoms...
  25. ncbi Quality of life in epilepsy, multiple sclerosis, and beyond
    E Ray Dorsey
    Ann Neurol 62:307-8. 2007
  26. ncbi Financial anatomy of biomedical research
    Hamilton Moses
    The Alerion Institute, North Garden, Va 22959, USA
    JAMA 294:1333-42. 2005
    ....
  27. ncbi Influence of controllable lifestyle on recent trends in specialty choice by US medical students
    E Ray Dorsey
    Evanston Northwestern Healthcare, Chicago, Ill, USA
    JAMA 290:1173-8. 2003
    ..Recent specialty choices of graduating US medical students suggest that lifestyle may be an increasingly important factor in their career decision making...